STERIS Balance Sheet Health
Financial Health criteria checks 3/6
STERIS has a total shareholder equity of $6.4B and total debt of $3.3B, which brings its debt-to-equity ratio to 51.5%. Its total assets and total liabilities are $11.4B and $5.0B respectively. STERIS's EBIT is $849.0M making its interest coverage ratio 6.3. It has cash and short-term investments of $195.6M.
Key information
51.5%
Debt to equity ratio
US$3.31b
Debt
| Interest coverage ratio | 6.3x |
| Cash | US$195.59m |
| Equity | US$6.43b |
| Total liabilities | US$5.01b |
| Total assets | US$11.44b |
Recent financial health updates
STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet
Mar 07
We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt
Nov 06These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well
Feb 01STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Nov 01Is STERIS (NYSE:STE) A Risky Investment?
Jul 19STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Apr 08Recent updates
Steris: Moving On, Losing Its Teeth
Apr 14STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price
Mar 29STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet
Mar 07Steris: Strong Healthcare Products Growth Coupled With Weak AST Business
Feb 17STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't
Feb 15An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued
Dec 17Should You Investigate STERIS plc (NYSE:STE) At US$203?
Nov 24Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes
Nov 08We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt
Nov 06Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?
Sep 18Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage
Sep 01When Should You Buy STERIS plc (NYSE:STE)?
Aug 10Steris: Continuing To Grow The Product Lineup
Jun 20Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered
Feb 09Steris declares $0.47 dividend
Feb 01These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well
Feb 01Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)
Dec 28Steris declares $0.47 dividend
Nov 02STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Nov 01Steris: Non-GAAP Valuations Supportive Of Substantial Upside
Sep 04STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47
Aug 18STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47
Aug 04Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M
Aug 02Is STERIS (NYSE:STE) A Risky Investment?
Jul 19Steris: Deleveraging Key Undercurrent, Valuation A Concern
Jun 12STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Apr 08Steris: Another Essential Healthcare Supply Resource
Feb 01Is STERIS (NYSE:STE) A Risky Investment?
Dec 15STERIS (NYSE:STE) Is Increasing Its Dividend To US$0.43
Nov 01Financial Position Analysis
Short Term Liabilities: STE's short term assets ($2.2B) exceed its short term liabilities ($913.7M).
Long Term Liabilities: STE's short term assets ($2.2B) do not cover its long term liabilities ($4.1B).
Debt to Equity History and Analysis
Debt Level: STE's net debt to equity ratio (48.4%) is considered high.
Reducing Debt: STE's debt to equity ratio has increased from 40% to 51.5% over the past 5 years.
Debt Coverage: STE's debt is well covered by operating cash flow (28.2%).
Interest Coverage: STE's interest payments on its debt are well covered by EBIT (6.3x coverage).